Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v2.4.1.9
Statements of Operations (USD $)
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Operating expenses:    
Research and development $ 2,422,106us-gaap_ResearchAndDevelopmentExpense $ 2,665,339us-gaap_ResearchAndDevelopmentExpense
General and administrative 2,272,970us-gaap_GeneralAndAdministrativeExpense 2,122,625us-gaap_GeneralAndAdministrativeExpense
Total operating expenses 4,695,076us-gaap_OperatingExpenses 4,787,964us-gaap_OperatingExpenses
Loss from operations (4,695,076)us-gaap_OperatingIncomeLoss (4,787,964)us-gaap_OperatingIncomeLoss
Other income (expense):    
Interest income (expense), net 55,368us-gaap_InterestIncomeExpenseNet (827,995)us-gaap_InterestIncomeExpenseNet
Refundable state tax credits   328,516us-gaap_IncomeTaxCreditsAndAdjustments
Change in fair value of warrant and embedded derivative liabilities (212,055)cfrx_ChangeInFairValueOfWarrantAndEmbeddedDerivativeLiabilities 74,631cfrx_ChangeInFairValueOfWarrantAndEmbeddedDerivativeLiabilities
Total other income (expense) (156,687)us-gaap_NonoperatingIncomeExpense (424,848)us-gaap_NonoperatingIncomeExpense
Net loss $ (4,851,763)us-gaap_NetIncomeLoss $ (5,212,812)us-gaap_NetIncomeLoss
Per share information:    
Net loss per share of common stock, basic and diluted $ (0.24)us-gaap_EarningsPerShareBasicAndDiluted $ (5.15)us-gaap_EarningsPerShareBasicAndDiluted
Basic and diluted weighted average shares outstanding 20,221,463us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 1,011,997us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted